These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29214068)

  • 41. Quality of life after interventions for malignant pleural effusions: a systematic review.
    Sivakumar P; Saigal A; Ahmed L
    BMJ Support Palliat Care; 2020 Mar; 10(1):45-54. PubMed ID: 31243020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Relationship of Pleural Manometry With Postthoracentesis Chest Radiographic Findings in Malignant Pleural Effusion.
    Chopra A; Judson MA; Doelken P; Maldonado F; Rahman NM; Huggins JT
    Chest; 2020 Feb; 157(2):421-426. PubMed ID: 31472154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. OPTIMUM: a protocol for a multicentre randomised controlled trial comparing Out Patient Talc slurry via Indwelling pleural catheter for Malignant pleural effusion vs Usual inpatient Management.
    Sivakumar P; Douiri A; West A; Rao D; Warwick G; Chen T; Ahmed L
    BMJ Open; 2016 Oct; 6(10):e012795. PubMed ID: 27798020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between Tunneled Pleural Catheter Use and Infection in Patients Immunosuppressed from Antineoplastic Therapy. A Multicenter Study.
    Wilshire CL; Chang SC; Gilbert CR; Akulian JA; AlSarraj MK; Asciak R; Bevill BT; Davidson KR; Delgado A; Grosu HB; Herth FJF; Lee HJ; Lewis JE; Maldonado F; Ost DE; Pastis NJ; Rahman NM; Reddy CB; Roller LJ; Sanchez TM; Shojaee S; Steer H; Thiboutot J; Wahidi MM; Wright AN; Yarmus LB; Gorden JA
    Ann Am Thorac Soc; 2021 Apr; 18(4):606-612. PubMed ID: 33026887
    [No Abstract]   [Full Text] [Related]  

  • 45. Tunneled Pleural Catheter Placement with and without Talc Poudrage for Treatment of Pleural Effusions Due to Congestive Heart Failure.
    Majid A; Kheir F; Fashjian M; Chatterji S; Fernandez-Bussy S; Ochoa S; Cheng G; Folch E
    Ann Am Thorac Soc; 2016 Feb; 13(2):212-6. PubMed ID: 26598967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A propensity-matched comparison of pleurodesis or tunneled pleural catheter for heart failure patients with recurrent pleural effusion.
    Freeman RK; Ascioti AJ; Dake M; Mahidhara RS
    Ann Thorac Surg; 2014 Jun; 97(6):1872-6; discussion 1876-7. PubMed ID: 24726601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnosis and management of malignant pleural effusions.
    Heffner JE
    Respirology; 2008 Jan; 13(1):5-20. PubMed ID: 18197908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thoracoscopic talc pleurodesis for malignant pleural effusion.
    Love D; White D; Kiroff G
    ANZ J Surg; 2003; 73(1-2):19-22. PubMed ID: 12534732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malignant pleural effusions: a review.
    Thomas JM; Musani AI
    Clin Chest Med; 2013 Sep; 34(3):459-71. PubMed ID: 23993817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transforming growth factor-β1 rise in pleural fluid after tunneled pleural catheter placement: pilot study.
    Shojaee S; Voelkel N; Farkas L; de Wit M; Lee HJ
    J Bronchology Interv Pulmonol; 2013 Oct; 20(4):304-8. PubMed ID: 24162112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of malignant pleural effusions: questions that need answers.
    Davies HE; Lee YC
    Curr Opin Pulm Med; 2013 Jul; 19(4):374-9. PubMed ID: 23673450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contemporary best practice in the management of malignant pleural effusion.
    Koegelenberg CFN; Shaw JA; Irusen EM; Lee YCG
    Ther Adv Respir Dis; 2018; 12():1753466618785098. PubMed ID: 29952251
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of indwelling pleural catheters for the treatment of malignant pleural effusions.
    Syer T; Walker S; Maskell N
    Expert Rev Respir Med; 2019 Jul; 13(7):659-664. PubMed ID: 31177915
    [No Abstract]   [Full Text] [Related]  

  • 54. Malignant pleural effusion and cancer of unknown primary site: a review of literature.
    Awadallah SF; Bowling MR; Sharma N; Mohan A
    Ann Transl Med; 2019 Aug; 7(15):353. PubMed ID: 31516899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contemporary approach to the patient with malignant pleural effusion complicating lung cancer.
    Epelbaum O; Rahman NM
    Ann Transl Med; 2019 Aug; 7(15):352. PubMed ID: 31516898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of Malignant Pleural Effusion: A Cost-Utility Analysis.
    Shafiq M; Frick KD; Lee H; Yarmus L; Feller-Kopman DJ
    J Bronchology Interv Pulmonol; 2015 Jul; 22(3):215-25. PubMed ID: 26165892
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contemporary Approach to the Diagnosis of Malignant Pleural Effusion.
    Kaul V; McCracken DJ; Rahman NM; Epelbaum O
    Ann Am Thorac Soc; 2019 Sep; 16(9):1099-1106. PubMed ID: 31216176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
    Kolschmann S; Ballin A; Gillissen A
    Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Malignant pleural effusion in the palliative care setting.
    Arber A; Clackson C; Dargan S
    Int J Palliat Nurs; 2013 Jul; 19(7):320, 322-5. PubMed ID: 24273808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and Safety of Povidone-iodine Pleurodesis in Malignant Pleural Effusions.
    Kahrom H; Aghajanzadeh M; Asgari MR; Kahrom M
    Indian J Palliat Care; 2017; 23(1):53-56. PubMed ID: 28216863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.